Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

Demyelinating optic neuritis (DON) is a hallmark feature ... Fingolimod is associated with a 0.5–0.6% of macular edema, usually presenting within the first 3–4 months; diagnosis usually ...

Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

OCS-05 demonstrates safety and efficacy in treating acute optic neuritis ... a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following ...

Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic nerve in ... 3 trial in diabetic macular edema.

a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro ...

The company is developing OCS-01, a topical eye drop candidate for treating diabetic macular edema and inflammation ... a neuroprotective candidate for acute optic neuritis. The growing optimism ...